These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7066175)

  • 1. Intravenous propranolol in patients with inflammation.
    Waller DG; Smith CL; Renwick AG; George CF
    Br J Clin Pharmacol; 1982 Apr; 13(4):577-8. PubMed ID: 7066175
    [No Abstract]   [Full Text] [Related]  

  • 2. beta-blocker plasma concentrations and inflammatory disease: clinical implications.
    Schneider RE; Bishop H
    Clin Pharmacokinet; 1982; 7(4):281-4. PubMed ID: 7116736
    [No Abstract]   [Full Text] [Related]  

  • 3. Early kinetics of intravenous propranolol.
    Fagan TC; Walle T; Walle UK; Conradi EC; Harmon G; Gaffney TE
    Br J Clin Pharmacol; 1982 Apr; 13(4):571-4. PubMed ID: 7066173
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological determinants of propranolol disposition in man.
    Kornhauser DM; Wood AJ; Vestal RE; Wilkinson GR; Branch RA; Shand DG
    Clin Pharmacol Ther; 1978 Feb; 23(2):165-74. PubMed ID: 620476
    [No Abstract]   [Full Text] [Related]  

  • 5. The disposition of propranolol. I. Elimination during oral absorption in man.
    Shand DG; Rangno RE
    Pharmacology; 1972; 7(3):159-68. PubMed ID: 5054586
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.
    Schneider RE; Babb J; Bishop H; Mitchard M; Hoare AM
    Br Med J; 1976 Oct; 2(6039):794-5. PubMed ID: 974614
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability of propranolol in the dog.
    Tse FL; Sanders TM; Reo JP
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma propranolol concentrations and the erythrocyte sedimentation rate.
    Schneider RE; Bishop H; Hawkins CF
    Br J Clin Pharmacol; 1979 Jul; 8(1):43-7. PubMed ID: 552296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug binding to alpha 1-glycoprotein.
    Schneider RE; Bishop H; Hawkins CF; Kitis G
    Lancet; 1979 Mar; 1(8115):554. PubMed ID: 85135
    [No Abstract]   [Full Text] [Related]  

  • 10. Arterial and venous blood sampling in pharmacokinetic studies: propranolol in rabbits and dogs.
    Lam G; Chiou WL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):33-48. PubMed ID: 7268207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.
    Evans GH; Shand DG
    Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations.
    Castleden CM; George CF; Short MD
    Br J Clin Pharmacol; 1978 Feb; 5(2):121-2. PubMed ID: 619945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma propranolol levels in adults with observations in four children.
    Shand DG; Nuckolls EM; Oates JA
    Clin Pharmacol Ther; 1970; 11(1):112-20. PubMed ID: 5410893
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct measurement of propranolol bioavailability during accumulation to steady-state.
    Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG
    Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presystemic and systemic glucuronidation of propranolol.
    Walle T; Fagan TC; Conradi EC; Walle UK; Gaffney TE
    Clin Pharmacol Ther; 1979 Aug; 26(2):167-72. PubMed ID: 455886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.
    Cleaveland CR; Shand DG
    Clin Pharmacol Ther; 1972; 13(2):181-5. PubMed ID: 4401564
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacokinetics of propranolol.
    Routledge PA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma propranolol before, during, and after cardiopulmonary bypass.
    Plachetka JR; Salomon NW; Copeland JG
    Clin Pharmacol Ther; 1981 Dec; 30(6):745-51. PubMed ID: 7307425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of chronic inflammatory disease: universal and tissue-specific concepts.
    Schett G; Neurath MF
    Nat Commun; 2018 Aug; 9(1):3261. PubMed ID: 30111884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.